These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 12639367)

  • 41. Effects of tibolone on climacteric symptoms and quality of life in breast cancer patients--data from LIBERATE trial.
    Sismondi P; Kimmig R; Kubista E; Biglia N; Egberts J; Mulder R; Planellas J; Moggio G; Mol-Arts M; Kenemans P
    Maturitas; 2011 Dec; 70(4):365-72. PubMed ID: 22030384
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Tibolone treatment of diabetic postmenopausal women: clinical and laboratory safety parameters].
    Freitas AK; Freitas RA; Prado MF; Azevedo GD; Foss MC; Silva-de-Sá MF; Ferriani RA
    Arq Bras Endocrinol Metabol; 2005 Jun; 49(3):433-40. PubMed ID: 16543999
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Nortriptyline versus fluoxetine in the treatment of depression and in short-term recovery after stroke: a placebo-controlled, double-blind study.
    Robinson RG; Schultz SK; Castillo C; Kopel T; Kosier JT; Newman RM; Curdue K; Petracca G; Starkstein SE
    Am J Psychiatry; 2000 Mar; 157(3):351-9. PubMed ID: 10698809
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Tibolone].
    Jamin C; Poncelet C; Madelenat P
    Presse Med; 2002 Sep; 31(28):1314-22. PubMed ID: 12355994
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Tibolone: the way to beat many a postmenopausal ailments.
    Lazovic G; Radivojevic U; Marinkovic J
    Expert Opin Pharmacother; 2008 Apr; 9(6):1039-47. PubMed ID: 18377345
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Randomized, double-blind comparison of venlafaxine and fluoxetine in outpatients with major depression.
    Costa e Silva J
    J Clin Psychiatry; 1998 Jul; 59(7):352-7. PubMed ID: 9714263
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Reboxetine versus fluoxetine: an overview of efficacy and tolerability.
    Massana J
    J Clin Psychiatry; 1998; 59 Suppl 14():8-10. PubMed ID: 9818624
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Superior antidepressant efficacy results of agomelatine versus fluoxetine in severe MDD patients: a randomized, double-blind study.
    Hale A; Corral RM; Mencacci C; Ruiz JS; Severo CA; Gentil V
    Int Clin Psychopharmacol; 2010 Nov; 25(6):305-14. PubMed ID: 20856123
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Tibolone and the promise of ideal hormone-replacement therapy.
    El-Hajj Fuleihan G
    N Engl J Med; 2008 Aug; 359(7):753-5. PubMed ID: 18703480
    [No Abstract]   [Full Text] [Related]  

  • 50. [Differential effects on serum IGF-1 of tibolone (5 mg/day) vs combined continuous estrogen/progestagen in post menopausal women].
    Porcile A; Gallardo E; Duarte P; Aedo S
    Rev Med Chil; 2003 Oct; 131(10):1151-6. PubMed ID: 14692305
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A comparison of fluvoxamine and fluoxetine in the treatment of major depression.
    Rapaport M; Coccaro E; Sheline Y; Perse T; Holland P; Fabre L; Bradford D
    J Clin Psychopharmacol; 1996 Oct; 16(5):373-8. PubMed ID: 8889909
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Noradrenaline-selective versus serotonin-selective antidepressant therapy: differential effects on social functioning.
    Dubini A; Bosc M; Polin V
    J Psychopharmacol; 1997; 11(4 Suppl):S17-23. PubMed ID: 9438229
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Residual symptoms in depressed patients who respond acutely to fluoxetine.
    Nierenberg AA; Keefe BR; Leslie VC; Alpert JE; Pava JA; Worthington JJ; Rosenbaum JF; Fava M
    J Clin Psychiatry; 1999 Apr; 60(4):221-5. PubMed ID: 10221281
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effect on sexual life--a comparison between tibolone and continuous combined conjugated equine estrogens and medroxyprogesterone acetate.
    Uygur D; Yeşildaglar N; Erkaya S
    Gynecol Endocrinol; 2005 Apr; 20(4):209-12. PubMed ID: 16019363
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effects of tibolone on the breast of postmenopausal women.
    Wang PH; Cheng MH; Chao HT; Chao KC
    Taiwan J Obstet Gynecol; 2007 Jun; 46(2):121-6. PubMed ID: 17638619
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Nitric oxide in postmenopausal women taking three different HRT regimens.
    Kesim MD; Aydin Y; Erdemir M; Atis A
    Maturitas; 2005 Jan; 50(1):52-7. PubMed ID: 15590214
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Efficacy and response time to sertraline versus fluoxetine in the treatment of unipolar major depressive disorder.
    Suri RA; Altshuler LL; Rasgon NL; Calcagno JL; Frye MA; Gitlin MJ; Hwang S; Zuckerbrow-Miller J
    J Clin Psychiatry; 2000 Dec; 61(12):942-6. PubMed ID: 11206600
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Treatment approaches to major depressive disorder relapse. Part 2: reinitiation of antidepressant treatment.
    Fava M; Schmidt ME; Zhang S; Gonzales J; Raute NJ; Judge R
    Psychother Psychosom; 2002; 71(4):195-9. PubMed ID: 12097784
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Tibolone for the treatment of moderate to severe vasomotor symptoms and genital atrophy in postmenopausal women: a multicenter, randomized, double-blind, placebo-controlled study.
    Swanson SG; Drosman S; Helmond FA; Stathopoulos VM
    Menopause; 2006; 13(6):917-25. PubMed ID: 17006377
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effects of hormone replacement therapy and tibolone on skin thickness and bone in postmenopausal women.
    Demir B; Adabag A; Ozturk N; Gunes M
    Ann Saudi Med; 2006; 26(2):161-2. PubMed ID: 16761464
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.